Phospholamban-to-SERCA2 ratio controls the force-frequency relationship.

Area of Science:

• Cardiology
• Molecular Biology
• Physiology

Background:

• The force-frequency relationship (FFR) is crucial for cardiac contractility.
• The sarcoplasmic reticulum Ca2+-adenosinetriphosphatase (SERCA2) and its inhibitor phospholamban (PLB) are key regulators of calcium handling in the heart.
• The interplay between SERCA2 and PLB is hypothesized to influence FFR.

Purpose of the Study:

• To investigate the role of the phospholamban (PLB) to SERCA2 ratio in controlling the cardiac force-frequency relationship (FFR).
• To determine how modulating the PLB/SERCA2 ratio affects myocyte contractility and relaxation dynamics.

Main Methods:

• Adult rabbit cardiac myocytes were genetically modified using adenovirus vectors to overexpress SERCA2, PLB, or a control (beta-galactosidase).
• The relative PLB/SERCA2 ratios were quantified in each group.
• Contractility and relaxation parameters were measured at different stimulation frequencies (0.1 Hz and 1.5 Hz).
• FFR was also assessed in papillary muscles from SERCA2 transgenic mice.

Main Results:

• Overexpression of SERCA2 decreased the PLB/SERCA2 ratio, shortened relaxation time, and resulted in a negative FFR (-15%).
• Overexpression of PLB increased the PLB/SERCA2 ratio, prolonged relaxation, reduced contractility, and led to an augmented positive FFR (+78%).
• Control myocytes exhibited a positive FFR (+30%), while SERCA2 transgenic mouse papillary muscles also showed a more negative FFR.

Conclusions:

• The ratio of phospholamban to SERCA2 is a critical determinant of the cardiac force-frequency relationship.
• Modulating SERCA2 and PLB levels significantly alters cardiac contractility and the heart's response to changes in stimulation frequency.